AddLife completed the acquisition of BonsaiLab.

AddLife, a group that comprises approximately 25 operating subsidiaries that mainly operates in the Nordic Life Science market, completed the acquisition of BonsaiLab, a biotech company providing a portfolio of market-leading instruments and consumables in the field of cell and molecular biology. Financial terms were not disclosed. ”I am very excited about the new opportunities, and relevant experience, that AddLife will bring to BonsaiLab. The move will enable further expansion on the Iberian market and being part of the larger AddLife Group with a broad European presence is an exciting development for our employees, our suppliers, and our customers. I look forward to leading BonsaiLab into the next chapter of our journey as we continue to develop and grow," Rafael Calderón, BonsaiLab CEO.